Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
   M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
     M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
       M01AA Butylpyrazolidines
       M01AB Acetic acid derivatives and related substances
       M01AC Oxicams
       M01AE Propionic acid derivatives
       M01AG Fenamates
       M01AH Coxibs
       M01AX Other antiinflammatory and antirheumatic agents, non-steroids
         M01AX01 Nabumetone
         M01AX02 Niflumic acid
           D08275  Niflumic acid (INN)
         M01AX04 Azapropazone
         M01AX05 Glucosamine [DG:DG00760]
         M01AX07 Benzydamine [DG:DG00014]
         M01AX12 Glucosaminoglycan polysulfate
         M01AX13 Proquazone
         M01AX14 Orgotein
         M01AX17 Nimesulide
         M01AX18 Feprazone
         M01AX21 Diacerein
         M01AX22 Morniflumate
         M01AX23 Tenidap [DG:DG00761]
         M01AX24 Oxaceprol
         M01AX25 Chondroitin sulfate [DG:DG00762]
         M01AX26 Avocado and soyabean oil, unsaponifiables
         M01AX68 Feprazone, combinations
     M01B ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION
     M01C SPECIFIC ANTIRHEUMATIC AGENTS
   M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
     M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
       M02AA Antiinflammatory preparations, non-steroids for topical use
         M02AA01 Phenylbutazone [DG:DG00745]
         M02AA02 Mofebutazone
         M02AA03 Clofezone
         M02AA04 Oxyphenbutazone [DG:DG00746]
         M02AA05 Benzydamine [DG:DG00014]
         M02AA06 Etofenamate
         M02AA07 Piroxicam [DG:DG00752]
         M02AA08 Felbinac [DG:DG00764]
         M02AA09 Bufexamac
         M02AA10 Ketoprofen [DG:DG00753]
         M02AA11 Bendazac [DG:DG00765]
         M02AA12 Naproxen [DG:DG00455]
         M02AA13 Ibuprofen [DG:DG00245]
         M02AA14 Fentiazac
         M02AA15 Diclofenac [DG:DG00441]
         M02AA16 Feprazone
         M02AA17 Niflumic acid
           D08275  Niflumic acid (INN)
         M02AA18 Meclofenamic acid [DG:DG00758]
         M02AA19 Flurbiprofen [DG:DG00755]
         M02AA21 Tolmetin [DG:DG00747]
         M02AA22 Suxibuzone
         M02AA23 Indometacin [DG:DG00241]
         M02AA24 Nifenazone
         M02AA25 Aceclofenac
         M02AA26 Nimesulide
         M02AA27 Dexketoprofen
         M02AA28 Piketoprofen [DG:DG01250]
       M02AB Capsaicin and similar agents
       M02AC Preparations with salicylic acid derivatives
       M02AX Other topical products for joint and muscular pain
   M03 MUSCLE RELAXANTS
   M04 ANTIGOUT PREPARATIONS
   M05 DRUGS FOR TREATMENT OF BONE DISEASES
   M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: March 16, 2020
According to WHO's ATC 2020

» Japanese version